Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Oncotargets and Therapy|October 31, 2017
Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4Roberto Buzzoni, Carlo Carnaghi, Jonathan Strosberg, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 2, 2006
Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utilityAejaz Nasir, Mats Stridsberg, Jonathan Strosberg, et al.
Therapeutic Advances in Medical Oncology|August 2, 2023
HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumorsMilton J Barros, Jonathan Strosberg, Taymeyah Al-Toubah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2018
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 TrialJonathan Strosberg, Edward Wolin, Beth Chasen, et al.
Clinical Colorectal Cancer|March 22, 2015
Outcomes of Therasphere Radioembolization for Colorectal MetastasesAndrea M Abbott, Richard Kim, Sarah E Hoffe, et al.
JCO Oncology Practice|February 3, 2021
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial ImplementationCathy Eng, Emerson Y Chen, Jane Rogers, et al.
Cancer|April 21, 2021
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohortSandip Pravin Patel, Edward Mayerson, Young Kwang Chae, et al.
The Lancet. Oncology|September 16, 2015
Consensus on biomarkers for neuroendocrine tumour diseaseKjell Oberg, Irvin M Modlin, Wouter De Herder, et al.
Seminars in Cancer Biology|March 30, 2025
Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosisMatteo Tacelli, Manuel Gentiluomo, Paolo Biamonte, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2024
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine NeoplasmsMichele Borghesani, Anna Reni, Eleonora Lauricella, et al.
Pageof 12